Contingent Value Rights would reward continuous holders with additional shares as the Company meets defined price milestones
BELLEVUE, WA / ACCESS Newswire / June 25, 2026 / OSR Health, Inc. (NASDAQ:OSRH) today announced a Shareholder Loyalty Program designed to reward the investors who hold OSRH stock over the long term. Under the program, the Company plans to distribute non-transferable Contingent Value Rights ("CVRs") to all shareholders of record tentatively as of July 31, 2026. One CVR for every share owned. The Board of Directors has authorized management to proceed with implementation, subject to receipt of a legal opinion confirming the applicable securities law requirements have been complied with.
The concept is simple. As OSRH share price reaches a series of defined milestones over the twelve months following the record date, shareholders who continuously hold their shares would automatically receive additional shares of common stock, at no additional cost - no purchase, no exercise, and no additional investment required.
The CVR Program
For every share owned on the record date, a shareholder would receive one CVR. Each CVR can deliver additional shares as the stock reaches higher price levels and the holder stays invested:
Tier / Holding Period | Price Trigger | CVR Delivery | Cumulative Position |
Tier 1 - 3 months | ≥ $2.00 | 0.5 new shares per CVR | 1.5× original position |
Tier 2 - 6 months | ≥ $3.00 | 1.0 new shares per CVR | 2.5× original position |
Tier 3 - 9 months | ≥ $4.00 | 1.5 new shares per CVR | 4.0× original position |
Tier 4 - 12 months | ≥ $5.00 | 2.0 new shares per CVR | 6.0× original position |
The tiers are cumulative. A shareholder who holds throughout the period, if all four milestones are achieved, would receive a total of five additional shares for each share originally held - growing their position to six times its original size.
The program reflects management's belief that OSRH is approaching an important inflection point, supported by catalysts including the VXM01 global licensing opportunity and the U.S. and international market potential for Woori IO's non-invasive glucose monitor.
"We designed this program for the shareholders who believe in the future OSR Health is building," said Peter Hwang, Chief Executive Officer of OSRH. "Too often, the investors who stay the course get no special recognition for their conviction, and we want to change that. It's an ideal corporate action to welcome in our inflection point - not a mechanical reverse split, but a genuine reward for the loyal shareholders who believe in our vision. As we deliver on our potential and our shareholders stay with us, they share directly in our success: additional shares, not fewer. It's a simple idea, and a deeper alignment between the Company and the people who own it."